We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$126B
Cap. Flow %
-18.88%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Technology 1.6%
2 Consumer Discretionary 1.3%
3 Financials 0.99%
4 Communication Services 0.86%
5 Healthcare 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCICW
12726
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$25K ﹤0.01%
+46,176
New +$29.4K
HCICW
12727
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
$25K ﹤0.01%
+30,677
New +$32.5K
ELOX
12728
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$25K ﹤0.01%
866
-260
-23% -$11.3K
EVOL
12729
DELISTED
Evolving Systems, Inc.
EVOL
$25K ﹤0.01%
+10,974
New +$26.7K
CYCN icon
12730
PUT
Cyclerion Therapeutics
CYCN
$19.4M
$24K ﹤0.01%
695
-185
-21% -$8.74K
ORGNW
12731
DELISTED
Origin Materials Inc Warrants
ORGNW
$24K ﹤0.01%
+16,104
New +$25.8K
RKDA icon
12732
CALL
Arcadia Biosciences
RKDA
$1.24M
$24K ﹤0.01%
568
-521
-48% -$34K
UTSI icon
12733
UTStarcom
UTSI
$22.4M
$24K ﹤0.01%
+6,928
New +$30.4K
ORTX
12734
PUT
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$24K ﹤0.01%
1,800
-6,740
-79% -$111K
FRTX
12735
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$24K ﹤0.01%
+2,332
New +$41.9K
RONI.WS
12736
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$24K ﹤0.01%
+16,312
New +$25.3K
SREV
12737
PUT
DELISTED
ServiceSource International, Inc.
SREV
$24K ﹤0.01%
+24,700
New +$29.1K
PEI
12738
CALL
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$24K ﹤0.01%
1,587
-6,566
-81% -$141K
GAU
12739
Galiano Gold
GAU
$620M
$23K ﹤0.01%
32,393
-2,519
-7% -$1.93K
PL.WS
12740
DELISTED
Planet Labs PBC Warrants
PL.WS
$23K ﹤0.01%
+11,693
New +$25.7K
SLDPW icon
12741
Solid Power Inc Warrant
SLDPW
$5.66M
$23K ﹤0.01%
+10,149
New +$31.2K
VTGN icon
12742
CALL
VistaGen Therapeutics
VTGN
$11.5M
$23K ﹤0.01%
393
-210
-35% -$13.7K
VCNX
12743
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$23K ﹤0.01%
105
-39
-27% -$14.1K
PHUNW
12744
DELISTED
Phunware, Inc. Warrants
PHUNW
$23K ﹤0.01%
+14,849
New +$28.4K
KAIRW
12745
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$23K ﹤0.01%
48,231
AYTU icon
12746
PUT
AYTU BioPharma
AYTU
$24.7M
$22K ﹤0.01%
815
-2,685
-77% -$116K
CBUS icon
12747
Cibus
CBUS
$128M
$22K ﹤0.01%
207
-163
-44% -$23.7K
CRBP icon
12748
CALL
Corbus Pharmaceuticals
CRBP
$219M
$22K ﹤0.01%
1,183
-4,394
-79% -$119K
LSTA icon
12749
CALL
Lisata Therapeutics
LSTA
$16.3M
$22K ﹤0.01%
1,720
+480
+39% +$7.41K
FEED
12750
ENvue Medical Inc
FEED
$4.19M
$22K ﹤0.01%
+10
New +$29.7K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass withdrew a net $126B in Q4 2021, closing 1,571 positions and reducing 6,197 holdings. Its most notable exit was Stamps.com, Inc., an estimated $78.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in iShares Core MSCI Emerging Markets ETF worth $78.2M.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.